Abstract:The great challenge in developing safe medications for placenta-derived diseases is to reduce or eliminate fetal drug exposure while still providing the necessary therapeutic effect. Rapid advances in nanotechnology have brought opportunities for the therapy of placenta-derived disease through accumulating the drug in the placenta while reducing its placental penetration. Among various nanocarriers, liposomes are regarded as an ideal type of carrier for placental drug delivery due to their biosafety and biodegradability. However, their placental retention effect with different particle sizes has not been studied. This research aimed to explore a suitable size of liposomes for placenta drug delivery. Cy 5 dye was chosen as a model molecule for tracing the distribution of three different-sized liposomes (similar to 80 nm, 200 nm, and 500 nm) in ICR pregnant mice. The stability, cytotoxicity, and cellular uptake study of Cy 5-loaded liposomes were performed. The in vivo fluorescence studies on ICR pregnant mice suggested that the particle size of liposomes was positively correlated with the degree of liposome aggregation in the placenta. The ratio of fluorescence in the placenta and fetus section (P/F value) was proposed to evaluate the placental retention effect of different-sized liposomes. The results showed that the liposomes with 500 nm had the highest P/F value and thus exhibited the strongest placental retention effect and the weakest placental penetration ability. Moreover, liquid chromatography-mass spectrometry analysis confirmed the reliability of the fluorescence section analysis in exploring the placental retention effect of nanovehicles. In general, this study introduced a simple and intuitive method to evaluate the placental retention effect of nanoplatforms and defined a suitable size of liposomes for placenta-derived disease drug delivery.

Relationship Between Particle Size and Lung Retention Time of Intact Solid Lipid Nanoparticle Suspensions after Pulmonary Delivery.

Size-dependent Placental Retention Effect of Liposomes in ICR Pregnant Mice: Potential Superiority in Placenta-Derived Disease Therapy

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Nanocarriers with long-term retention in the respiratory system for prolonged drug exposure

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

Exploring the influence of microstructure and phospholipid type of liposomes on their interaction with lung

Nanoparticle Translocation Across the Lung Surfactant Film Regulated by Grafting Polymers.

Development of Aggregation-Caused Quenching Probe-Loaded Pressurized Metered-Dose Inhalers with Fluorescence Tracking Potentials

Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles

Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung

Evidence Does Not Support Absorption of Intact Solid Lipid Nanoparticles Via Oral Delivery.

Size-dependent translocation and lymphatic transportation of polymeric nanocarriers post intraperitoneal administration

Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Promote Potential Applications of Nanoparticles As Respiratory Drug Carrier: Insights from Molecular Dynamics Simulations

Environment-responsive Aza-Bodipy Dyes Quenching in Water As Potential Probes to Visualize the in Vivo Fate of Lipid-Based Nanocarriers.

In Vivo Biodistribution and Pharmacokinetics of Silica Nanoparticles As A Function of Geometry, Porosity and Surface Characteristics

Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models

Near‐infrared Fluorophores with Absolute Aggregation‐caused Quenching and Negligible Fluorescence Re‐illumination for in Vivo Bioimaging of Nanocarriers

Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation Via Oral Delivery

Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles